PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-13.69%
Both yoy net incomes decline, with BB at -356.06%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.48%
Both reduce yoy D&A, with BB at -12.89%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-7.95%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
1.86%
SBC growth while BB is negative at -33.33%. John Neff would see competitor possibly controlling share issuance more tightly.
92.76%
Well above BB's 178.60% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
151.30%
AR growth while BB is negative at -36.82%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-131.49%
Negative yoy inventory while BB is 1372.22%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-218.94%
Both negative yoy AP, with BB at -874.36%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
15.42%
Lower 'other working capital' growth vs. BB's 293.39%. David Dodd would see fewer unexpected short-term demands on cash.
3.32%
Lower 'other non-cash' growth vs. BB's 19942.86%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
128.85%
Operating cash flow growth above 1.5x BB's 43.75%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
31.18%
CapEx growth well above BB's 26.32%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-12.95%
Both yoy lines negative, with BB at -12.69%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-62.45%
Both yoy lines negative, with BB at -0.84%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
32.86%
Below 50% of BB's 94.52%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-72.46%
We reduce yoy other investing while BB is 12.69%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-317.95%
We reduce yoy invests while BB stands at 175.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
48.98%
Debt repayment growth of 48.98% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
20.51%
Issuance growth of 20.51% while BB is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
12.68%
Buyback growth below 50% of BB's 100.00%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.